The Bionics Institute is internationally renowned. It has a 30-year track record of excellence in clinically focused hearing research and development (R&D). It specialises in custom device design and fabrication, pre-clinical, safety and efficacy testing of devices, imaging, novel drug-delivery systems, psychophysical testing, 'first in human trials', gene therapy and clinical research/testing.
The Institute is highly experienced at partnering with industry in a number of ways, including via collaborative partnerships or through the provision of contract research services.
CILcare is a contract-research organisation that launched in 2014 as a spin-out from Sanofi in Montpellier, France. CILcare specialises in hearing disorders, and offers a range of services, via both fee-for-service contracts, and risk-sharing collaboration.
Pre-clinical services include in-vitro and in-vivo pharmacological models for hearing loss and tinnitus-drug discovery, and customised design of pre-clinical, proof-of-concept studies for pharmaceutical or biologic drug candidates. CILcare also offers expertise in clinical-trial design, clinical-outcome measures of efficacy, and patient selection. To learn more, please contact firstname.lastname@example.org
NIHR Nottingham Biomedical Research Centre
Our partners at the Nottingham Biomedical Research Centre are experts in a range of disciplines, including Ear, Nose and Throat (ENT), audiology, health psychology and cognitive psychology. The centre's research interest in hearing spans the whole spectrum, from mild to profound degrees of hearing loss. It has specific interests in hearing-related conditions such as tinnitus and hyperacusis.
Nottingham BRC's National Institute for Health Research (NIHR) infrastructure funding supports early-phase clinical research, with interests in robust clinical-trial design. Find out more about the facilities and access to state-of-the-art research equipment.
The NIHR UCL Hospitals Biomedical Research Centre Deafness and Hearing Problems
The NIHR UCLH BRC Deafness and Hearing Problems theme builds on the unique partnership of the UCL Ear Institute and UCLH Royal National Throat, Nose and Ear Hospital; this partnership provides the infrastructure and excellence to develop and deliver targeted and transformative hearing therapies. Our expertise spans the translational pathway, ranging from discovery science to early and late phase clinical trials and health policy. The Ear Institute’s laboratories include state-of-the-art facilities for molecular analysis, cellular imaging, brain electrophysiology, and auditory functional testing, and our dedicated clinical research rooms and equipment at the Royal National Throat, Nose and Ear Hospital ensure our trials can be delivered efficiently and to the highest standard.
NIHR Manchester Biomedical Research Centre
NIHR Manchester Biomedical Research Centre’s Hearing Health researchers are world leading in the development of new tests and treatments that improve people’s lives. They are tackling hearing loss from birth to older ages.
Multidisciplinary expertise includes audiology, hearing science, ENT, engineering and signal processing, biomaterials, auditory genetics, health psychology, health informatics, biomarkers, child development and communication.
The UK’s only Hearing Device Research Centre, Manchester Biomedical Research Centre offers consultancy services for translational and applied research. It also provides expertise in audiology healthcare education and training and bespoke Clinical Research Facilities for adults and children.
Nouveau Clinical, IncNouveau Clinical offers clinical trial planning, clinical research site selection, medical consulting and project management services.
Their client base includes biotechnology companies headquartered in the USA, Europe and Australia who are developing new vaccines, therapeutics and devices for infectious, pulmonary, cardiovascular, gastrointestinal diseases and hearing loss.
Their network of esteemed sites and partners include University Hospitals Cleveland Medical Center, John Hopkins Bayview Medical Center, Infectious Solutions, LLC, and Action on Hearing Loss.
LifeArc is the new name for MRC Technology, a medical research charity with a 25 year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients. The new name reflects the charity’s purpose: to be the arc or bridge between research and improving patients’ lives.
LifeArc is pioneering new ways to turn great science into greater patient impact. It brings together a network of partners to tackle specific diseases and directly funds academic and early stage research.
So far, LifeArc’s work has helped to develop four drugs (Keytruda®, Actemra®, Tysabri® and Entyvio®) and a test for antimicrobial resistance.